ational Cancer Institute Cancer Awareness Risk assessment and Early detection of Prostate Oral Head Neck Cancers
Not Applicable
- Registration Number
- CTRI/2022/11/047056
- Lead Sponsor
- Bayer Pharmaceuticals Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adults 35 years and above residing in the geographical areas near NCI
Exclusion Criteria
Those with previous diagnosis of cancer will be excluded.
Those with age <35 years will not be included.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Cancer Risk factors (demographic, metabolic, dietary, lifestyle, smoking/tobacco, pesticide use etc.) <br/ ><br>2. Clinical examination findings (BMI, Blood pressure, Heart rate) <br/ ><br>3. Clinical measures (HbA1c, Urine albumin & protien, Lipid profile, Hemoglobin etc) <br/ ><br>4. PSA (Total & Free) for males above 45 years of age <br/ ><br>5. <br/ ><br>5. Finding of oral visual examination and oral imaging. <br/ ><br>6. Finding of Head & neck clinical examination such as lymph node, thyroid mass/lump. <br/ ><br> <br/ ><br>Timepoint: Baseline and annually till end of study period. <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.Cancer Knowledge and attitudes (Cancer awareness & disease perception)Timepoint: Baseline and annually till end of study of period.